# ABACAVIR SULFATE; LAMIVUDINE
> **NDA202007** · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2011-05-12
## Drug
- **FDA Application Number:** NDA202007
- **Application type:** New Drug Application
- **Brand name:** ABACAVIR SULFATE; LAMIVUDINE
- **Generic name:** Abacavir Sulfate
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2011-05-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202007)
---
*AI Analytics · CC0 1.0*